Dr. James Eubanks was awarded $25,000 in 2016 for his study: Testing new read-through drugs for prospective treatment of Rett Syndrome.



In 2019, Dr. Eubanks was awarded a second grant of $50,000 for his project entitled A Preclinical Trial In MeCP2-Deficient Mice To Test The Repurposing Potential Of An FDA-Approved Drug For Use In Rett Syndrome.

Dr. James Eubanks was awarded $25,000 in 2016 for his study: Testing new read-through drugs for prospective treatment of Rett Syndrome. In 2019, Dr. Eubanks was awarded a second grant of $50,000 for his project entitled A Preclinical Trial In MeCP2-Deficient Mice To Test The Repurposing Potential Of An FDA-Approved Drug For Use In Rett Syndrome.

Dr. James Eubanks

Interviews with grant recipients from the Ontario Rett Syndrome Association's Hope Fund.

The Hope Fund exists solely to fund Canadian research to find a cure and/or treatment for Rett syndrome. 100% of all dollars within this fund go directly to research. It is currently the only fund dedicated to Rett syndrome research in Canada.

Since the creation of The Hope Fund in 2014, ORSA has awarded over $600,000 in research grants.

To help fund The Hope Fund, please make a donation at rett.ca/donate.

Medicine

Health & Fitness

Education

Interviews with grant recipients from the Ontario Rett Syndrome Association's Hope Fund. The Hope Fund exists solely to fund Canadian research to find a cure and/or treatment for Rett syndrome. 100% of all dollars within this fund go directly to research. It is currently the only fund dedicated to Rett syndrome research in Canada. Since the creation of The Hope Fund in 2014, ORSA has awarded over $600,000 in research grants. To help fund The Hope Fund, please make a donation at rett.ca/donate.

Share Dr. James Eubanks

Sign up to save your podcasts

Dr. James Eubanks

Dr. James Eubanks